Senator Tim Scott brags on Roper St. Francis on Capitol Hill

Disability Insurance
6 followers
7 Video Views·Jun 12, 2025
Senator Tim Scott spoke about the groundbreaking research and work of the Roper St. Francis Clinical Biotechnology Research Institute. Senator Scott’s statements came during a U.S. Senate Special Committee on Aging hearing about the fight against Alzheimer’ Disease. “It’s a great opportunity for me to spend some time talking about the success we’ve had at home in South Carolina,” Senator Scott said.
Senator Scott. Senator Scott, welcome. Thank you, Chairwoman Collins. Thank you
for holding this hearing and giving us all an opportunity to really interface
with so many people that are committed to the cause and for all those folks out
there with the purple lawn today, thank you for your investment of your time and
your energy on such an incredibly important topic. I know that all of our
offices have been filled with your with your enthusiasm and your real-life
stories. I can't think of anyone here on on this panel who has not been impacted
personally by Alzheimer's and for me at least Alzheimer's and Parkinson's and
watching the the challenges of your loved ones. My grandmother passed away
April 29th 2001 and just seeing that the devastation and the challenges that she
faced but also for those who have been support systems. If you've had to have
you've been blessed with the opportunity to care for someone with
Alzheimer's, would you raise your hands? God bless you and thank you. It's amazing
the impact that the disease has not only on the patient but on the family and on
the loved ones and it's such a powerful witness that the folks that stopped by
my office today spent a lot of time talking about their loved ones, their
commitment to making sure that the research and the resources are available
for the others who may be impacted by the disease as well. So I thank you for
your your energy and your enthusiasm. It keeps all of us focused on the topic. My
question is for Dr. Hodes. Thank you for your your expertise and thank you for
your contribution here today. It's a great opportunity for me to
really spend some time talking about the success that we've had at home in
South Carolina, the Medical University of South Carolina and so many folks. Roper
St. Francis Hospital System that has invested a lot of time looking for the
resources to make progress. This Roper St. Francis in particular in
Charleston has received more than 20 million dollars in grants researching
treatments and caring for hundreds of Alzheimer patients each and every month.
Since 2006 the South Carolina Aging Research Network has also been doing
some really great work on this issue in conjunction with other hospitals and
research universities. There is still so much work to be done. I hear optimism
though from researchers in our state who believe that with the right resources
that they can do the most amazing things. The question I have for you doctor is
what does progress look like over the next 10 years from your perspective and
are we meeting the National Alzheimer's Project Act milestones and updating them
appropriately so that our researchers are working on the most critical
projects? Can you point to specific achievements in collaboration and
discovery since NAPA that has advanced the science on this issue? Thank you for
the comment Senator Scott. I think there is well justified and huge enthusiasm
about the potential for progress as we have a convergence on more and more
insight into basic molecular cellular mechanisms behind Alzheimer's disease. In
terms of the planning that is now in place is an intensified product of the
national plan. We on a regular basis most recently with the summit held
just last month here in Bethesda in the Washington area convene regularly experts
to help us to update and renew the areas of highest priority and then to establish
milestones just what we need to accomplish year by year in order to
translate those priorities into the success that is the objective of the
plan. In terms of some of the accomplishments that we've seen in
recent years as noted in some of my opening comments and comments for the
record we've seen progress in the ability to identify early stages of
Alzheimer's disease in individuals long before the appearance of symptoms giving
us opportunities that just didn't exist years ago to intervene with new
treatments aimed at newly identified molecular targets and to understand
whether they appear to be working or not by tracking biomarkers again long
before we would identify progression to symptomatic disease. This is an example
of the kind of progress we're making. I should add much as we're pursuing this
kind of research we're also committed to important work to sustain the quality of
life for those affected and their caregivers. The research proposals that
are coming from from your state and across the country are enormously
gratifying and exciting. Coupled with it I will say from our perspective is the
enormous disappointment in fact pain and anguish of the great number of those
meritorious applications that we were unable to support. So we are making
progress without question towards an ultimate goal. The pace of that progress
is being limited by the amount of research that we can support. Thank you
sir. Thank you very much senator. Senator Whitehouse.
